NanoViricides, Inc. (NNVC) Earnings History
Annual and quarterly earnings data from 2005 to 2025
Loading earnings history...
NNVC EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
NNVC Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
Download Data
Export NNVC earnings history in CSV or JSON format
Free sign-in required to download data
NanoViricides, Inc. (NNVC) Earnings Overview
As of May 8, 2026, NanoViricides, Inc. (NNVC) reported trailing twelve-month net income of -$2.22T, reflecting +10.0% year-over-year growth. The company earned $-111875.32 per diluted share over the past four quarters.
Looking at the long-term picture, NNVC's historical earnings data spans multiple years. The company achieved its highest annual net income of -$66,005 in fiscal 2005.
NanoViricides, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including SIGA (-$4.04T net income, 24.6% margin), COCP (-$10M net income), GILD ($9.22B net income, 28.9% margin), NNVC has comparable earnings metrics. Compare NNVC vs SIGA →
NNVC Earnings vs Peers
Earnings metrics vs comparable public companies
NNVC Historical Earnings Data (2005–2025)
21 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$9M | -14.1% | -$10M | $-0.63 | - | - |
| 2024 | -$8M | +3.4% | -$9M | $-0.70 | - | - |
| 2023 | -$9M | -5.9% | -$9M | $-0.74 | - | - |
| 2022 | -$8M | +8.1% | -$8M | $-0.70 | - | - |
| 2021 | -$9M | +34.4% | -$9M | $-0.81 | - | - |
| 2020 | -$13M | -63.1% | -$8M | $-2.39 | - | - |
| 2019 | -$8M | +3.7% | -$9M | $-2.30 | - | - |
| 2018 | -$9M | +16.9% | -$9M | $-2.64 | - | - |
| 2017 | -$10M | +3.9% | -$10M | $-3.43 | - | - |
| 2016 | -$11M | -387.9% | -$9M | $-3.72 | - | - |
See NNVC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NNVC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NNVC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNNVC — Frequently Asked Questions
Quick answers to the most common questions about buying NNVC stock.
Is NNVC growing earnings?
NNVC EPS stands at $-111875.32, with +10.0% growth matching the 5-year CAGR of N/A. TTM net income is $-2.2T. Earnings trajectory remains consistent.
What are NNVC's profit margins?
NanoViricides, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are NNVC's earnings?
NNVC earnings data spans 2005-2025. The current earnings trend is +10.0% YoY. Historical data enables comparison across business cycles.